A Genetically Truncated RGD-Containing Peptide rLj-RGD4 Exhibits Potent In Vivo Antitumor Activity via Induction of Multi-Pathway Apoptosis and EGFR-Targeted Signaling Suppression

Although the parental recombinant protein rLj-RGD3 exhibits antitumor activity, it carries immunogenicity risks owing to its large molecular size (13.5 kDa). We generated a genetically truncated mutant, rLj-RGD4 (6.27 kDa, four RGD motifs), which inhibited B16 melanoma cell proliferation, migration,...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Yuyao Song, Huijie Yan, Yuebin Zhang, Jingyu Zhang, Li Lv, Jihong Wang
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2026-04-01
Cyfres:	Molecules
Pynciau:	rLj-RGD4 peptide antitumor activity apoptosis internalization EGFR
Mynediad Ar-lein:	https://www.mdpi.com/1420-3049/31/8/1266
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!